Autonomix Medical Inc. (AMIX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Autonomix Medical Inc. (AMIX:NASDAQ), powered by AI.

Current Price
$0.40
P/E Ratio
-0.1
Market Cap
697,738
Sector
Healthcare
What is the Autonomix Medical Inc. stock price forecast?

Autonomix Medical Inc. is currently trading at $0.40. View real-time AI analysis on Alpha Lenz.

What is Autonomix Medical Inc. insider trading activity?

View the latest insider trading data for Autonomix Medical Inc. on Alpha Lenz.

What is Autonomix Medical Inc.'s P/E ratio?

Autonomix Medical Inc.'s P/E ratio is -0.1.

Autonomix Medical Inc.

$0.40
NASDAQAMIX
Ask about Autonomix Medical Inc.'s future dividend policy...
Alpha Chat Insight

Autonomix Medical Inc. trades at a P/E of -0.1 (undervalued) with modest ROE of -145.1%.

Ask for details

Company Overview

Autonomix Medical Inc. is a pioneering company in the healthcare sector, dedicated to advancing medical technology solutions. The company's primary focus is on the development and commercialization of automated systems designed to improve the quality and efficiency of medical procedures. Autonomix Medical Inc. stands out in the industry by providing cutting-edge solutions tailored to streamline complex surgical and diagnostic processes, enhancing precision and reducing human error. The company's innovations are particularly impactful in sectors such as minimally invasive surgery, where automation can bring significant improvements in patient outcomes and operational efficiency. By integrating technology such as robotics and software-driven platforms into healthcare practices, Autonomix Medical Inc. is contributing to a transformative shift towards smarter, data-driven medical environments. Its presence in the market is significant as it aligns with global trends towards digital health and automated healthcare management. As healthcare systems worldwide continue to seek improvements in both efficiency and patient care, Autonomix Medical Inc. plays a crucial role in offering solutions that meet these evolving needs.

CEOMr. Bradley Hauser
SectorHealthcare
IndustryMedical Devices
Employees8

Company Statistics

(FY 2025)

Profile

Market Cap$697.74K
Revenue$0.00
Shares Out0.00
Employees8

Margins

GrossN/A
EBITDAN/A
OperatingN/A
Pre-TaxN/A
NetN/A

Valuation

P/E-0.06
P/B0.09
EV/SalesN/A
EV/EBITDA0.76
P/FCF-0.08

Growth (CAGR)

Rev 3YrN/A
Rev 5YrN/A
Op Inc 3YrN/A
Op Inc 5YrN/A
Net Inc 3YrN/A
Net Inc 5YrN/A

Returns

ROA-118.77%
ROE-145.10%
ROIC-116.94%

Financial Health

Cash & Cash Equivalents$9.14M
Net Debt$-7.43M
Debt/Equity21.08%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Autonomix Medical Inc. (Healthcare) Stock Forecast & Analysis $0.40 | Alpha Lenz